China's API Industry Has Shown A Certain Warming Trend

- Apr 19, 2018 -

According to the latest data, in 2017, the main business revenue of China's chemical raw materials manufacturing industry reached 499.1 billion yuan, an increase of 14.68% compared with the same period last year, and 6.28 percentage points higher than the previous year's growth rate. API exports reached $29.1 billion, up 13.7 percent year on year, returning to positive growth after two years of modest adjustments.

The existence of global rigid demand is the biggest impetus to maintain the development of China's API industry. At present, the global API market is about 150 billion us dollars, and will continue to grow at a steady rate of about 5%. API market demand also embodies in the export of active pharmaceutical ingredients in China, in 2015 and 2016, although active pharmaceutical ingredients in China exports fell 0.91% and 0.06% respectively, but the export quantity increased 4.44% and 13.04% respectively, export quantity even hit a record high, and continue to grow by 8.33% in 2017, 8.9615 million tons.

It is undeniable that there is still a large variety of overcapacity in China's raw drug industry and the competition disorder of small varieties monopolizing price increases. Countries push supply side structural reforms in recent years, mainly depends on the regulation and guide the way to phase out backward production capacity, encourage API transformation and upgrading of enterprises, and at the same time increase the intensity of API specification market, to crack down on illegal price increases and malicious control pin.

On the one hand, improve environmental standards, by reasonable guide leading enterprise technological level to enhance competitiveness, to high pollution not compliance companies exit the market, reduce API market low-cost competitors; On the other hand, it issued a guide to the price behavior of suppliers of shortage drugs and raw materials, and punished the behavior of malicious manipulation of the price of API.

The integration of production capacity, the improvement of process and the maintenance of reasonable profit will lay a more solid foundation for the sustainable and healthy development of China's API industry in the future.

Related News

Related Products

  • Diazonio-(4-methylphenyl)sulfonylazanide
  • 4-Fluoro-2-methoxy-1-nitrobenzene
  • C15H15N
  • 2,7-Dibromofluorene 16433-88-8
  • 5-[2-chloro-4-(trifluoromethyl) Phenoxy]-N-(methylsulfonyl) - 2-nitro-(72178-02-0)
  • 2-Methylsulfonyl-4,6-dimethoxypyrimidine